课题基金 / 基金详情

Analysis for Molecular Mechanism of Cardiomyocyte Differentiation by Using a Cell Line Which Efficiently Differentiates into Cardiomyocytes

Analysis for Molecular Mechanism of Cardiomyocyte Differentiation by Using a Cell Line Which Efficiently Differentiates into Cardiomyocytes
利用高效分化为心肌细胞的细胞系分析心肌细胞分化的分子机制
批准号:
12835003
负责人:
HAYASHI Doubun
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

HAYASHI Doubun的其他基金

相似基金

相关文献

中文摘要
翻译
了解心肌细胞分化和心脏发育的分子机制的基础研究目标包括建立诱导心肌细胞分化的遗传技术,这可能有助于组织再生和随后的心力衰竭基因治疗的实际治疗应用。从这方面来看,我们研究了心肌细胞分化的分子机制,通过使用心肌细胞系P19CL6,它可以有效地分化为跳动的心肌细胞。我们之前已经证明骨形态发生蛋白(BMPs)通过MAPKKK TAK1诱导心肌细胞分化。据报道,转录因子Smad在BMP信号传导中起关键作用,ATF/CREB家族转录因子ATF-2最近被证明是Smad和TAK1途径的共同核靶点。我们利用小鼠P19细胞的克隆衍生物P19CL6研究Smads和ATF-2是否参与心肌细胞分化。虽然P19CL6在二甲亚砜处理后能有效分化为心肌细胞,但P19CL6noggin(一种组成型过表达BMP拮抗剂noggin的P19CL6细胞系)不能分化为心肌细胞。Smadl(配体特异性Smad)和Smad4(常见介质Smad)的共同过表达恢复了P19CL6noggin向心肌细胞分化的能力,而Smad6(抑制性Smad)的稳定过表达完全阻断了P19CL6的分化,这表明Smad途径是心肌细胞分化所必需的。ATF-2通过与Smad1/4和TAK1的协同方式刺激βMHC启动子活性,而ATF-2显性阴性形式的过表达降低了几个心脏特异性基因的启动子活性,抑制了P19CL6的心肌细胞分化。这些结果表明Smads、TAK1和它们的共同靶点ATF-2协同在心肌细胞分化中起关键作用。少
英文摘要
The aims of basic research for understanding the molecular mechanism of cardiomyocyte differentiation and cardiac development include the establishment of the genetic technique by which cardiomyocyte differentiation can be induced, which may contribute to the practical therapeutic application for tissue regeneration and the subsequent gene-therapy for heart failure. From this respect, we investigated the molecular mechanism by which cardiomyocyte differentiation is regulated by using a cardiomyogenic cell line, P19CL6, which can differentiate efficiently into beating cardiomyocytes.We previously demonstrated that bone morphogenetic proteins (BMPs) induce cardiornyocyte differentiation through the MAPKKK TAK1. Transcription factors Smads have been reported to play a critical role in BMP signaling and the ATF/CREB family transcription factor ATF-2 has recently been shown to be a common nuclear target of the Smad and the TAK1 pathways. We here examined whether Smads and ATF-2 are involved … More in cardiomyocyte differentiation using P19CL6, a clonal derivative of murine P19 cells. Although P19CL6 efficiently differentiates into cardiomyocytes when treated with dimethyl sulfbxide, P19CL6noggin, a P19CL6 cell line constitutively overexpressing the BMP antagonist noggin, did not differentiate into cardiomyocytes. Co-overexpression of Smadl, a ligand-specific Smad, and Smad4, a common mediator Smad, restored the ability of P19CL6noggin to differentiate into cardiomyocytes, whereas stable overexpression of Smad6, an inhibitory Smad, completely blocked differentiation of P19CL6, suggesting that the Smad pathway is necessary for cardiomyocyte differentiation. ATF-2 stimulated βMHC promoter acitvity by the synergistic manner with Smad1/4 and TAK1, while overexpression of the dominant negative form of ATF-2 reduced the promoter activities of several cardiac-specific genes and inhibited cardiomyocyte differentiation of P19CL6. These results suggest that Smads, TAK1, and their common target ATF-2 cooperatively play a critical role in cardiomyocyte differentiation. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
林同文: "基本的な薬の使い方Consensus & Controversy"診断と治療社. 593 (2000)
Tongbun Hayashi:《基本用药共识与争议》诊断与治疗出版593(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Smads, TAKI, and their common target ATF-2 play a crinical role in cardiomyocyte differentiation.
Smads、TAKI 及其共同靶标 ATF-2 在心肌细胞分化中发挥着关键作用。
DOI: --
发表时间: 2001
期刊: J Cell Biol. 153(4)
影响因子: --
作者: [Monzen K., et. al.]
通讯作者: et. al.
林同文: "循環器大規模臨床試験要約集2000年度版"オーシーシー・ジャパン株式会社. 243 (2000)
Dobun Hayashi:《大规模心血管临床试验总结 2000 年版》 OCC Japan Co., Ltd. 243 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Construction of Clinical Trail Designs Database and Development of Security System for Personal Information Protection
    • 批准号:
      17606001
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      HAYASHI Doubun
    • 依托单位:
    Analysis of molecular mechanism in cardiomyocyte differentiation and its application for regeneration medicine using embryonic stem cells
    • 批准号:
      13557060
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.17万
    • 财政年份:
      2001
    • 负责人:
      HAYASHI Doubun
    • 依托单位:
    国内基金
    海外基金
    基于BMP2/Smad1/Runx2通路调控干细胞成骨分化及桃红四物汤促进骨折愈合的研究
    • 批准号:
      2026JJ80308
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      贺渊哲
    • 依托单位:
    基于菌群时间节律驱动GLU及BMP2/SMAD1诱导多能干细胞探讨太极拳改善老年慢性疼痛机制研究
    • 批准号:
      2026JJ70009
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张峰
    • 依托单位:
    RUNX1通过BMP2/Smad信号轴调控肿瘤相关巨噬细胞M2极化促进膀胱癌进展的机制研究
    • 批准号:
      2026JJ81626
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黎勇林
    • 依托单位:
    BMP/Smad调控牙周膜干细胞成骨作用与机制研究